Literature DB >> 28712001

In-hospital ischaemic stroke treated with intravenous thrombolysis or mechanical thrombectomy.

François Caparros1, Marc Ferrigno1, Amélie Decourcelle1, Anais Hochart1, Solène Moulin1, Nelly Dequatre1, Marie Bodenant1, Hilde Hénon1, Charlotte Cordonnier1, Didier Leys2.   

Abstract

Patients with in-hospital strokes (IHS) may be eligible for recanalization therapies. The objective of this study is to compare outcomes in patients with IHS and community-onset strokes (COS) treated by recanalization therapy. We analysed data prospectively collected in consecutive patients treated by thrombolysis, thrombectomy, or both for cerebral ischemia at the Lille University Hospital. We compared four outcomes measures at 3 months in patients with IHS and COS: (1) modified Rankin scale (mRS) 0-1, (2) mRS 0-2, (3) death, and (4) symptomatic intracranial haemorrhage (ECASS 2 definition). Of 1209 patients, 64 (5.3%) had IHS, with an increasing proportion over time (p = 0.001). Their median onset-to-needle time was 128 min vs. 145 in COS (p < 0.001). They were more likely to have had a recent TIA [odds ratio (OR) 30.1; 95% confidence interval (CI) 11.5-78.7], to have been treated by vitamin K antagonist before (OR 4.2; 95% CI 1.4-12.0) and to undergo mechanical thrombectomy (45 vs. 10%, p < 0.001). They were less likely to have a pre-stroke mRS 0-1 (OR 0.22; 95% CI 0.09-0.50). After adjustment, IHS was not associated with any of the four outcome measures. Patients with IHS are treated 17 min earlier than patients with COS, but, taking into account that they were already in the hospital, delays are still too long. Their outcome does not differ from that of patients with COS, suggesting room for improvement if delays can be reduced. IHS being frequent, pre-specified pathways should be organised.

Entities:  

Keywords:  Cerebral ischaemia; Haemorrhagic transformation; In-hospital stroke; Ischaemic stroke; Mechanical thrombectomy; Thrombolysis

Mesh:

Substances:

Year:  2017        PMID: 28712001     DOI: 10.1007/s00415-017-8570-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Stroke units from scientific evidence to practice: the experience of the Lille stroke unit.

Authors:  C Cordonnier; M Girot; E Dorp; P Rimetz; S Bouillaguet; H Hénon; C Lucas; O Godefroy; D Leys
Journal:  Cerebrovasc Dis       Date:  2000       Impact factor: 2.762

3.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

4.  Endovascular therapy for ischemic stroke with perfusion-imaging selection.

Authors:  Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

5.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 7.  In-hospital stroke.

Authors:  David J Blacker
Journal:  Lancet Neurol       Date:  2003-12       Impact factor: 44.182

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis.

Authors:  Jetan H Badhiwala; Farshad Nassiri; Waleed Alhazzani; Magdy H Selim; Forough Farrokhyar; Julian Spears; Abhaya V Kulkarni; Sheila Singh; Abdulrahman Alqahtani; Bram Rochwerg; Mohammad Alshahrani; Naresh K Murty; Adel Alhazzani; Blake Yarascavitch; Kesava Reddy; Osama O Zaidat; Saleh A Almenawer
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  7 in total

1.  Comparing characteristics and outcomes of in-hospital stroke and community-onset stroke.

Authors:  Zi-Yue Liu; Guang-Song Han; Juan-Juan Wu; Yu-Hui Sha; Yue-Hui Hong; Han-Hui Fu; Li-Xin Zhou; Jun Ni; Yi-Cheng Zhu
Journal:  J Neurol       Date:  2022-07-02       Impact factor: 6.682

2.  Outcomes between in-hospital stroke and community-onset stroke after thrombectomy: Propensity-score matching analysis.

Authors:  Kai Qiu; Qing-Quan Zu; Lin-Bo Zhao; Sheng Liu; Hai-Bin Shi
Journal:  Interv Neuroradiol       Date:  2021-09-13       Impact factor: 1.764

3.  Comparison between in-hospital stroke and community-onset stroke treated with endovascular thrombectomy.

Authors:  Min-Yi Lu; Chih-Hao Chen; Shin-Joe Yeh; Li-Kai Tsai; Chung-Wei Lee; Sung-Chun Tang; Jiann-Shing Jeng
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

4.  Comparison of Clinical Features, Immune-Inflammatory Markers, and Outcomes Between Patients with Acute In-Hospital and Out-of-Hospital Ischemic Stroke.

Authors:  Pei-Ya Chen; Guei-Chiuan Chen; Cheng-Lun Hsiao; Po-Jen Hsu; Fu-Yi Yang; Chih-Yang Liu; Adam Tsou; Wan-Ling Chang; Hsiu-Hsun Liu; Shinn-Kuang Lin
Journal:  J Inflamm Res       Date:  2022-02-09

5.  Evaluation of the Quality and Effect of 360° Safe Indwelling Infusion of Peripheral Venous Indwelling Needle in Pediatric Clinic.

Authors:  Qian Niu; Hongge Sun; Hongjuan Wu; Nannan Ma; Qiu Jin; Jianhua Qin; Xipin Zhang; Ting He
Journal:  J Healthc Eng       Date:  2022-04-07       Impact factor: 2.682

6.  Delays in initial workflow cause delayed initiation of mechanical thrombectomy in patients with in-hospital ischemic stroke.

Authors:  Kenichiro Suyama; Shoji Matsumoto; Ichiro Nakahara; Yoshio Suyama; Jun Morioka; Akiko Hasebe; Jun Tanabe; Sadayoshi Watanabe; Kiyonori Kuwahara; Yuichi Hirose
Journal:  Fujita Med J       Date:  2021-11-25

7.  [Analysis of intravenous thrombolysis time and prognosis in patients with in-hospital stroke].

Authors:  Congcong Zhang; Min Lou; Zhicai Chen; Hongfang Chen; Dongjuan Xu; Zhimin Wang; Haifang Hu; Chenglong Wu; Xiaoling Zhang; Xiaodong Ma; Yaxian Wang; Haitao Hu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.